Agile Therapeutics Current Ratio 2013-2019 | AGRX

Agile Therapeutics current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Agile Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.01B $0.00B 6.07
2019-03-31 $0.01B $0.00B 8.91
2018-12-31 $0.01B $0.00B 3.81
2018-09-30 $0.02B $0.01B 2.10
2018-06-30 $0.02B $0.01B 2.19
2018-03-31 $0.03B $0.01B 2.35
2017-12-31 $0.04B $0.01B 2.57
2017-09-30 $0.05B $0.01B 4.10
2017-06-30 $0.03B $0.01B 3.37
2017-03-31 $0.04B $0.01B 3.82
2016-12-31 $0.05B $0.01B 4.70
2016-09-30 $0.06B $0.01B 6.54
2016-06-30 $0.06B $0.01B 6.06
2016-03-31 $0.07B $0.01B 8.15
2015-12-31 $0.04B $0.01B 4.89
2015-09-30 $0.04B $0.01B 5.85
2015-06-30 $0.05B $0.01B 9.02
2015-03-31 $0.05B $0.01B 11.29
2014-12-31 $0.04B $0.01B 4.56
2014-09-30 $0.05B $0.01B 6.50
2014-06-30 $0.05B $0.01B 10.21
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2012-12-31 $0.02B $0.00B 9.65
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.050B $0.000B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.911B 9.47
Mylan (MYL) United Kingdom $9.559B 4.21
Bausch Health Cos (BHC) Canada $7.495B 5.00
Teva Pharmaceutical Industries (TEVA) Israel $6.999B 2.75
Dr Reddy's Laboratories (RDY) India $5.851B 19.69
ASPEN PHARMACR (APNHY) South Africa $2.022B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.422B 13.90
Amphastar Pharmaceuticals (AMPH) United States $1.010B 49.72
Voyager Therapeutics (VYGR) United States $0.791B 0.00
Homology Medicines (FIXX) United States $0.738B 0.00
CymaBay Therapeutics (CBAY) United States $0.400B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.343B 0.47
Akorn (AKRX) United States $0.341B 0.00
Assembly Biosciences (ASMB) United States $0.321B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.320B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.260B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.178B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.093B 0.00
Teligent (TLGT) United States $0.037B 0.00